These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35970284)

  • 1. Secondary Effects from Mass Azithromycin Administration: A Systematic Review and Meta-analysis.
    Li J; Xiong T; Yue Y; Choonara I; Qazi S; Tang J; Shi J; Wang H; Qu Y; Mu D
    Am J Trop Med Hyg; 2022 Oct; 107(4):904-911. PubMed ID: 35970284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.
    Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE
    BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of azithromycin mass drug administration on trachoma: a systematic review.
    Xiong T; Yue Y; Li WX; Choonara I; Qazi S; Chen HJ; Tang J; Shi J; Wang H; Zeng LN; Xia B; Qiao LN; Qu Y; Mu DZ
    Chin Med J (Engl); 2021 Sep; 134(24):2944-2953. PubMed ID: 34665571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks.
    Rolfe RJ; Shaikh H; Tillekeratne LG
    Infect Dis Poverty; 2022 Jun; 11(1):77. PubMed ID: 35773722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of nasopharyngeal
    Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
    Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia.
    Ebert CD; Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Ayele Z; Melak B; Chanyalew M; Gashaw B; Tadesse Z; Callahan EK; Jenness SM; Nash SD
    Trop Med Int Health; 2019 Apr; 24(4):493-501. PubMed ID: 30674087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
    Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Barry A; Tapily A; Nikiema F; Yerbanga S; Coumare S; Thera I; Traore A; Milligan P; Tinto H; Doumbo O; Ouedraogo JB; Greenwood B
    N Engl J Med; 2019 Jun; 380(23):2197-2206. PubMed ID: 30699301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping azithromycin mass drug administration for trachoma: A systematic review.
    Mahmud H; Landskroner E; Amza A; Aragie S; Godwin WW; de Hostos Barth A; O'Brien KS; Lietman TM; Oldenburg CE
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009491. PubMed ID: 34237074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania.
    Schachterle SE; Mtove G; Levens JP; Clemens E; Shi L; Raj A; Dumler JS; Munoz B; West S; Sullivan DJ
    Emerg Infect Dis; 2014 Jun; 20(6):941-9. PubMed ID: 24865642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
    Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.
    Burr SE; Milne S; Jafali J; Bojang E; Rajasekhar M; Hart J; Harding-Esch EM; Holland MJ; Mabey DC; Sillah A; Bailey RL; Roca A
    Bull World Health Organ; 2014 Jul; 92(7):490-8. PubMed ID: 25110374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.
    Seidman JC; Coles CL; Silbergeld EK; Levens J; Mkocha H; Johnson LB; Muñoz B; West SK
    Int J Epidemiol; 2014 Aug; 43(4):1105-13. PubMed ID: 24659584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for trachoma.
    Evans JR; Solomon AW; Kumar R; Perez Á; Singh BP; Srivastava RM; Harding-Esch E
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD001860. PubMed ID: 31554017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal seasonal timing of oral azithromycin for malaria.
    Gao D; Amza A; Nassirou B; Kadri B; Sippl-Swezey N; Liu F; Ackley SF; Lietman TM; Porco TC
    Am J Trop Med Hyg; 2014 Nov; 91(5):936-942. PubMed ID: 25223942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
    Gladstone RA; Bojang E; Hart J; Harding-Esch EM; Mabey D; Sillah A; Bailey RL; Burr SE; Roca A; Bentley SD; Holland MJ
    Clin Microbiol Infect; 2021 Jun; 27(6):864-870. PubMed ID: 32750538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
    Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD;
    PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.